Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer

Main Article Content

Marlinda Adham
Namira Kesuma Jelita
Djajadiman Gatot
Soehartati Argadikoesoema Gondhowiardjo
Lisnawati Rachmadi
Astrid E Greijer
I Bing Tan
Jaap M Middeldorp


Background Studies suggest that the most common type of nasopharyngeal carcinoma (NPC) is WHO-3, which is strongly associated with Epstein-Barr virus (EBV).

Objective To assess NPC patient characteristics in a national general referral hospital in Indonesia, with regards to EBV DNA load and treatment response.

Methods Twenty-three pediatric patients diagnosed with NPC were included in the study. Data collected were history, physical examination, tissue biopsy, CT scan, staging and EBV DNA load from nasopharyngeal (NP) brushing as well as blood specimens. The NP brushing, blood specimens and CT scan evaluations were done two months post-treatment.

Results Pediatric patients with symptoms such as  blood tinged secretion, lymph node enlargement, and nasal congestion were more likely to have higher EBV DNA loads in their NP brushings (P<0.05) (including T3 and higher). Despite significant reduction of EBV DNA load in NP brushing post-treatment, it was not associated with treatment response, as evaluated by CT scan.

Conclusion Higher DNA load from NP brushings is associated with a higher tumor stage. Larger sample size and follow-up data are needed to assess the usefulness of EBV DNA load assessment in pediatric patients.

Article Details

How to Cite
Adham M, Jelita N, Gatot D, Gondhowiardjo S, Rachmadi L, Greijer A, Tan I, Middeldorp J. Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer. PI [Internet]. 20Sep.2021 [cited 19Oct.2021];61(5):261-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2505
Pediatric Hemato-Oncology
Received 2020-10-20
Accepted 2021-09-20
Published 2021-09-20


1. Estimated age standardized incidence rates [Internet]. World Health Organization. 2018. [cited 2019 January 28]. Available from: http://gco.iarc.fr/today/online-analysis-multi-bars?v=2018&mode=cancer&mode_population=countries&population=900&populations=935&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=40&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Afalse%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D&population_group_globocan_id=#collapse-group-0-3.
2. Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T. Age incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev. 2008;17:2356-65. DOI: 10.1158/1055-9965.EPI-08-0461.
3. Wu SG, Liao XL, He ZY, Tang LY, Chen XT, Wang Y, et al. Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: a population-based analysis. Oral Oncol. 2017;73:83-7. DOI : 10.1016/j.oraloncology.2017.08.006.
4. Kontny U, Franzen S, Behrends U, Buhrlen M, Christiansen H, Delecluse H, et al. Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents - recommendations of the GPOH-NPC Study Group. Klin Padiatr. 2016;228:105-12. DOI : 10.1055/s-0041-111180.
5. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiarjo S, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs and symptoms at presentation. Chin J Cancer. 2012;31:186-96. DOI : 10.5732/cjc.011.10328.
6. Richards MK, Dahl JP, Gow K, Goldin AB, Doski J, Goldfarb M, et al. Factors associated with mortality in pediatric vs adult nasopharyngeal carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142:217-22. DOI : 10.1001/jamaoto.2015.3217.
7. Li C, Wang Y. Factors associated with early diagnosis in pediatric vs adult nasopharyngeal carcinoma. Acta Otolaryngol. 2018;138:56-9.DOI : 10.1080/00016489.2017.1371330.
8. Liu W, Tang Y, Gao L, Huang X, Luo J, Zhang S, et al. Nasopharyngeal carcinoma in children and adolescents - a single institution experience on 158 patients. Radiat Oncol. 2014;9:274. DOI : 10.1186/s13014-014-0274-7.
9. Zrafi WS, Tebra S, Tbessi S, Ouni S, Jebsi M, Bouaouina N. Undifferentiated carcinoma of nasopharyngeal type in children: clinical features and outcome. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:321-4. DOI : 10.1016/j.anorl.2017.03.002.
10. Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014;33:582-90. DOI : 10.5732/cjc.014.10197.
11. Lu S, Chang H, Sun X, Zhen Z, Sun F, Zhu J, et al. Long term outcomes of nasopharyngeal carcinoma in 148 children and adolescents. Medicine. 2016;95;e445. DOI : 10.1097/MD.0000000000003445.
12. Stevens S, Verkuijlen S, Hariwiyanto B, Harijadi, Paramita D, Fachiroh J, et al. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer. 2006;119:604-14. DOI : 10.1002/ijc.21914.
13. Zhang PF, Zheng XH, Li XZ, Tian T, Zhang SD, Hu YZ, et al. Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research. Cancer Commun. 2018;38:8. DOI : 10.1186/s40880-018-0278-z.
14. American Joint Committee on Cancer. AJCC Cancer Staging Form Supplement 8th edition. [internet]. Chicago. American Collage of Surgeons. [updated : 05 june 2018, cited 2019 January 28]. available from : https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwj7rOD-5o_yAhV5lEsFHaKDA5IQFjAAegQIBxAD&url=https%3A%2F%2Fcancerstaging.org%2Fabout%2Fnews%2Fdocuments%2Fncra%2520ajcc%2520cancer%2520staging%2520manual%25208th%2520edition%2520update.pdf&usg=AOvVaw3zoIbadehnpjzpjGe_PJSs.
15. World Health Organization. Nasopharyngeal Carcinoma. [internet]. Union for International Cancer Control. [Updated 2014, 2019 January 28] available from : https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwif2uzk6Y_yAhUe7XMBHVJxBToQFjAHegQICBAD&url=https%3A%2F%2Fwww.who.int%2Fselection_medicines%2Fcommittees%2Fexpert%2F20%2Fapplications%2FNasopharyngealCarcinoma.pdf&usg=AOvVaw1OmH0uCzRwWsgC1SvQqZP7.
16. Budach V. Concurrent chemoradiation. Encyclopedia of Radiation Oncology. 2013. DOI : 10.1007/978-3-540-85516-3_506.
17. Eisenhauer E, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline. Eur J Cancer. 2009;45:228-47. DOI : 10.1016/j.ejca.2008.10.026.
15.18. Stevens S, Verkuiljlen S, Middledorp J. Quantitative detection of Epstein Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods Mol Biol. 2005;292:15-26.DOI: 10.1385/1-59259-848-x:015
16.19. Mouden K, Kababri ME, Kili A, Majjaoi SE, Kacemi HE, Kebdani BE, et al. Nasopharyngeal carcinoma in childhood: analysis of a series of 64 patients treated with combined chemotherapy and radiotherapy. Cancer Ther Oncol. 2018;9:1-7.DOI : 10.19080/CTOIJ.2018.09.555758
17.20. Li FL. Annual Registry Report 2015. In: Registry SC, editor. Singapore: National Registry of Diseases Office; 2015.
18.21. Mak HW, Lee SH, Chee J, Tham I, Goh BC, Chao SS, et al. Clinical outcome among nasopharyngeal cancer patients in a multi-ethnic society in Singapore. PLoS One. 2015;10:e0126108. DOI : 10.1371/journal.pone.0126108.
19.22. Wu ZX, Xiang L, Rong JF, He HL, Li D. Nasopharyngeal carcinoma with headaches as the main symptom: a potential diagnostic pitfall. J Cancer Res Ther. 2016;12:209-14. DOI : 10.4103/0973-1482.157334.
20.23. Lee YL, Ho CY. Headache as the sole symptom of nasopharyngeal carcinoma and its clinical implication. Scientific World Journal. 2012;2012:143829. DOI : 10.1100/2012/143829.
24. Zheng XH, Lu LX, Li XZ, Jia WH. Quantification of Epstein Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China. Cancer Sci. 2015;106:1196-201. DOI : https://doi.org/10.1111/cas.12718.
21.25. Gondowiardjo SA, Handoko, Adham M, Rachmadi L, Kodrat H, Tobing DL, et al. Epstein-Barr Virus (EBV) viral load in tumor cells did not predict tumor extensiveness in nasopharyngeal cancer. Microbiol. Res. 2021 ; 12 p150-6. DOI : 10.3390/microbiolres12010011.
22.26. Adham M, Greijer A, Verkujlen SA, Juwana H, Fleig S, Rachmadi L, et al. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment. Clin Cancer Res. 2013;19:2175-86. DOI : 10.1158/1078-0432.CCR-12-2897.
27. Gurtsevitch V, Senyuta N, Ignatova A, Lomaya M, Kondratova V, Pavlovskaya A, et al. Epstein-Barr virus biomarkers for nasopharyngeal carcinoma in non-endemic regions. J Gen Virol. 2017;98:2118-27. DOI : 10.1099/jgv.0.000889.